GSK Operating Cash Flow (Statement)

GSK plc American Depositary Shares (Each representing two Ordinary Shares) · Operating Cash Flow (Statement)

GSK logo

GSK Operating Cash Flow (Statement)

Latest reported£2.54B GBP
GSK Quarterly Cash from Operations · GBP (£1.19B → £2.54B)
High-resolution chart · PNG

GSK operating cash flow (statement) history

Quarterly · GBP. Dates are reporting period ends; fiscal years can differ from calendar years.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) Operating Cash Flow (Statement) — Quarterly (GBP)
Period endingOperating Cash Flow (Statement) (GBP)
2,535,512,578
1,141,000,000
2,036,332,673
3,027,580,859
2,096,000,000
1,145,000,000
2,329,000,000
2,154,000,000
1,113,000,000
1,190,599,417
3,618,516,824
2,212,000,000
1,307,000,000
53,000,000
1,749,852,325
1,450,363,160
1,635,000,000
2,542,000,000
4,702,868,153
3,503,836,117
1,349,830,497
331,000,000
4,626,559,347
861,000,000
2,760,000,000
965,000,000
3,453,000,000
2,515,000,000
1,389,000,000
663,000,000
4,119,000,000
2,077,000,000
1,362,000,000
863,000,000
2,869,000,000
1,897,000,000
1,008,000,000
1,144,000,000
2,991,000,000
1,767,000,000
1,236,000,000
503,000,000
1,501,000,000
481,000,000
217,000,000
370,000,000
2,210,000,000
1,273,000,000
766,000,000
927,000,000
2,187,000,000
2,077,000,000
1,711,000,000
1,247,000,000
1,914,000,000
-288,000,000
1,737,000,000
1,012,000,000
2,146,000,000
1,828,000,000
1,289,000,000
987,000,000
1,465,000,000
1,094,000,000
2,116,000,000
2,122,000,000
2,261,000,000
2,081,000,000
1,763,000,000
1,736,000,000
2,138,000,000
1,893,000,000
1,373,000,000
1,801,000,000
1,657,977,500
1,742,000,000
1,237,000,000
1,530,000,000
1,737,838,940
-113,000,000
1,035,000,000
1,696,000,000
1,621,890,000
1,719,000,000
1,424,000,000
1,192,000,000
361,222,080
488,605,620
1,783,000,000
1,332,000,000
-846,720,000
2,341,000,000
2,284,560,180
1,071,808,230
409,000,000
2,143,000,000
2,101,000,000
1,449,000,000
-60,547,230
1,698,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.